AEterna Zentaris Inc.

AEterna Zentaris Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. AEterna Zentaris Inc. is not very popular among insiders. AEterna Zentaris Inc. is a mediocre stock to choose.
Log in to see more information.
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developin...
AEZS Fundamental Data by TradingView

News

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.
Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

Globe Newswire TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical...\n more…

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

Globe Newswire TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and...\n more…

Aeterna Zentaris announces last patient last visit in DETECT-trial
Aeterna Zentaris announces last patient last visit in DETECT-trial

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Globe Newswire Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( Aeterna or...\n more…

Aeterna Zentaris and Ceapro Announce Merger Completion
Aeterna Zentaris and Ceapro Announce Merger Completion

TipRanks Financial Blog Aeterna Zentaris (TSE:AEZS) has released an update. Aeterna Zentaris Inc. and Ceapro Inc. have officially completed their merger, creating a more diversified biopha...\n more…

Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

PR Newswire Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s...\n more…